Health Care: Drugs

PDL BioPharma Inc (PDLI: NASDAQ)

$7.85 -0.03 | -0.38%
11/20/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 442.92M 374.52M 362.04M 344.98M
Cost of Sales 5.64M 0.00 0.00 0.00
Gross Operating Profit 437.28M 374.52M 362.04M 344.98M
Selling, General, and Administrative Expenses 29.76M 25.47M 16.16M 133.90M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 407.53M 349.06M 345.89M 211.08M
Depreciation & Amortization 18.55M 14.65M 11.32M 9.25M
Interest Income 19.22M 7.11M 593.00K 0.00
Other Income - Net 0.00 0.00 -766.00K -17.18M
Special Income / Charges 0.00 0.00 -2.12M 0.00
Total Income Before Interest Expenses (EBIT) 408.19M 341.52M 332.26M 184.65M
Interest Expense 24.87M 29.04M 36.10M 43.53M
Pre-Tax Income 383.32M 312.48M 296.16M 141.12M
Income Taxes 137.35M 115.46M 108.04M 58.50M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 264.53M 211.67M 199.39M 91.87M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 264.53M 211.67M 199.39M 91.87M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 264.53M 211.67M 199.39M 91.87M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
264.53M 211.67M 201.51M 91.87M
Preferred Dividends
Net Income Available To Common 264.53M 211.67M 199.39M 91.87M
Basic EPS from Continuing Ops. 1.89 1.52 1.43 0.73
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.89 1.52 1.43 0.73
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.89 1.52 1.43 0.73
Basic Normalized Net Income/Share 1.89 1.52 1.44 0.73
EPS fr Continuing Ops. 1.66 1.45 1.12 0.54
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.66 1.45 1.12 0.54
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.03 0.00
EPS, Total 1.66 1.45 1.15 0.54
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.66 1.45 1.14 0.54
Dividends Paid per Share 0.60 0.60 0.60 1.00

Portfolios with PDLI

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter